Get informed when a big investor buys or sells
+ FollowLoading insider trades…
Loading congress trades…
| Market cap | $39,538.00 |
|---|---|
| Enterprise Value | $26.63 Million |
| Earnings per Share | $-1.53 |
| Beta | 0.86 |
| Outstanding Shares | 131,793,000 |
| P/E Ratio | 0 |
|---|---|
| PEG | 0 |
| Price to Sales | - |
| Price to Book Ratio | -0.0 |
| Enterprise Value to Revenue | 145.21 |
| Enterprise Value to EBIT | -2.2 |
| Enterprise Value to Net Income | -2 |
| Total Debt to Enterprise | 1 |
| Debt to Equity | -1.72 |
No data
No data available for the latest quarter.
No data available for the latest quarter.
Marizyme, Inc. is a life sciences company primarily engaged in bringing innovative medical technologies from development to market. Its offerings include DuraGraft, a unique single-application treatment administered during vascular and b...